Follow
Wenyan Jiang
Wenyan Jiang
The Rockefeller University, Columbia University
Verified email at rockefeller.edu
Title
Cited by
Cited by
Year
Multiplex genome engineering using CRISPR/Cas systems
L Cong, FA Ran, D Cox, S Lin, R Barretto, N Habib, PD Hsu, X Wu, ...
Science 339 (6121), 819-823, 2013
152102013
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
W Jiang, D Bikard, D Cox, F Zhang, LA Marraffini
Nature biotechnology 31 (3), 233-239, 2013
25732013
Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system
D Bikard, W Jiang, P Samai, A Hochschild, F Zhang, LA Marraffini
Nucleic acids research 41 (15), 7429-7437, 2013
11272013
Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials
D Bikard, CW Euler, W Jiang, PM Nussenzweig, GW Goldberg, X Duportet, ...
Nature biotechnology 32 (11), 1146-1150, 2014
7572014
Co-transcriptional DNA and RNA cleavage during type III CRISPR-Cas immunity
P Samai, N Pyenson, W Jiang, GW Goldberg, A Hatoum-Aslan, ...
Cell 161 (5), 1164-1174, 2015
3982015
Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting
GW Goldberg, W Jiang, D Bikard, LA Marraffini
Nature 514 (7524), 633-637, 2014
2642014
Dealing with the evolutionary downside of CRISPR immunity: bacteria and beneficial plasmids
W Jiang, I Maniv, F Arain, Y Wang, BR Levin, LA Marraffini
PLoS genetics 9 (9), e1003844, 2013
2312013
CRISPR-Cas: new tools for genetic manipulations from bacterial immunity systems
W Jiang, LA Marraffini
Annual review of microbiology 69, 209-228, 2015
2082015
Degradation of phage transcripts by CRISPR-associated RNases enables type III CRISPR-Cas immunity
W Jiang, P Samai, LA Marraffini
Cell 164 (4), 710-721, 2016
1942016
Crispr-cas component systems, methods and compositions for sequence manipulation
F Zhang, L Cong, DBT Cox, P Hsu, LIN Shuailiang, RAN Fei, RJ Platt, ...
US Patent App. 14/105,035, 2014
1892014
Crispr-cas component systems, methods and compositions for sequence manipulation
F Zhang, DBT Cox, L Marraffini, DO Bikard, W Jiang
US Patent App. 14/497,627, 2015
1692015
CRISPR–Cas systems exploit viral DNA injection to establish and maintain adaptive immunity
JW Modell, W Jiang, LA Marraffini
Nature 544 (7648), 101-104, 2017
1362017
A ruler protein in a complex for antiviral defense determines the length of small interfering CRISPR RNAs
A Hatoum-Aslan, P Samai, I Maniv, W Jiang, LA Marraffini
Journal of Biological Chemistry 288 (39), 27888-27897, 2013
1212013
Crispr-cas component systems, methods and compositions for sequence manipulation
F Zhang, DBT Cox, L Marraffini, DO Bikard, W Jiang, NE Sanjana
US Patent App. 15/887,377, 2018
922018
CRISPR-assisted editing of bacterial genomes
W Jiang, D Bikard, D Cox, F Zhang, LA Marraffini
Nature biotechnology 31 (3), 233, 2013
802013
a.(2013) Multiplex Genome Engineering Using CRISPR/Cas Systems
L Cong, FA Ran, D Cox, S Lin, R Barretto, N Habib, PD Hsu, X Wu, ...
Science 339 (6121), 819-823, 0
74
Prokaryotic single-cell RNA sequencing by in situ combinatorial indexing
SB Blattman, W Jiang, P Oikonomou, S Tavazoie
Nature microbiology 5 (10), 1192-1201, 2020
702020
Impact of different target sequences on type III CRISPR-Cas immunity
I Maniv, W Jiang, D Bikard, LA Marraffini
Journal of bacteriology 198 (6), 941-950, 2016
442016
Development of sequence-specific antimicrobials based on programmable CRISPR-Cas nucleases
D Bikard, C Euler, W Jiang, PM Nussenzweig, GW Goldberg, X Duportet, ...
Nature biotechnology 32 (11), 1146, 2014
432014
Incomplete prophage tolerance by type III-A CRISPR-Cas systems reduces the fitness of lysogenic hosts
GW Goldberg, EA McMillan, A Varble, JW Modell, P Samai, W Jiang, ...
Nature communications 9 (1), 1-12, 2018
362018
The system can't perform the operation now. Try again later.
Articles 1–20